Indication
Carcinosarcoma
5 clinical trials
8 products
Product
BLU-222Clinical trial
A Phase 1/2 Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of BLU-222 as a Single Agent and in Combination Therapy for Patients With Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2025-11-30
Product
RibociclibProduct
CarboplatinProduct
FulvestrantProduct
PaclitaxelClinical trial
A Phase 2 Study Evaluating the Efficacy and Safety of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial, Epithelial Ovarian Cancer, or CarcinosarcomaStatus: Completed, Estimated PCD: 2020-09-09
Product
DKN-01Clinical trial
Phase II Trial of Single-Agent Nivolumab in Patients With Microsatellite Unstable/Mismatch Repair Deficient/Hypermutated Uterine CancerStatus: Completed, Estimated PCD: 2024-04-01
Product
NivolumabClinical trial
A Phase 2 Trial of ZW25 in HER2 Overexpressed Advanced Endometrial Cancers and Carcinosarcomas (ZW25-IST-2)Status: Completed, Estimated PCD: 2024-03-08
Product
ZW25